Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Chapman Christopher C JR | 0001340428 | Aug-02-2023 | director, officer: Executive Chairman |
Vorhoff David C | 0001342020 | Aug-02-2023 | director |
Kaplin Adam | 0001858042 | Aug-02-2023 | officer: Pres. & Chief Scientific Off. |
McColl Hugh III | 0001934476 | Aug-02-2023 | director |
Yanez Michelle | 0001958023 | Aug-02-2023 | officer: CFO, Secretary & Treasurer |
Nicholoudis Christos | 0001984816 | Aug-02-2023 | director |
Kroenig Bradley | 0001985521 | Aug-02-2023 | director |
Aminov Erez | 0001986112 | Aug-02-2023 | director, officer: Chief Executive Officer |
Tuck Talhia | 0001986139 | Aug-02-2023 | director |
Cappy George | 0001986372 | Aug-02-2023 | 10 percent owner |
Bay Shore Trust | 0001986593 | Aug-02-2023 | 10 percent owner |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Mira1a Therapeutics, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001493152-23-032935 (33 Act) Size: 8 KB |
Sep-18-2023 | 231261761 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-23-032778 (34 Act) Size: 3510 KB |
Sep-15-2023 | 231259250 |
8-K | Document | Current report filing Acc-no: 0001493152-23-031363 (34 Act) Size: 261 KB |
Aug-31-2023 | 231229835 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000897069-23-001265 ( Act) Size: 7 KB |
Aug-24-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001493152-23-029734 ( Act) Size: 5 KB |
Aug-21-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001493152-23-029735 ( Act) Size: 5 KB |
Aug-21-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001493152-23-029733 ( Act) Size: 5 KB |
Aug-21-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001493152-23-029732 ( Act) Size: 5 KB |
Aug-21-2023 | |
SC 13D | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000897069-23-001176 (34 Act) Size: 59 KB |
Aug-14-2023 | 231172151 |
8-K | Document | Current report filing Acc-no: 0001493152-23-027053 (34 Act) Size: 1016 KB |
Aug-07-2023 | 231148497 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000897069-23-001091 ( Act) Size: 8 KB |
Aug-04-2023 | |
424B4 | Document | Prospectus filed pursuant to Rule 424(b)(4) Acc-no: 0001493152-23-026760 (33 Act) Size: 2685 KB |
Aug-04-2023 | 231143106 |
424B1 | Document | Prospectus filed pursuant to Rule 424(b)(1) Acc-no: 0001493152-23-026758 (33 Act) Size: 2679 KB |
Aug-04-2023 | 231143097 |
EFFECT | Document | Acc-no: 9999999995-23-002261 (33 Act) Size: 1 KB | Aug-02-2023 | 231137820 |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000897069-23-001074 ( Act) Size: 21 KB |
Aug-02-2023 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000897069-23-001072 ( Act) Size: 5 KB |
Aug-02-2023 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000897069-23-001070 ( Act) Size: 12 KB |
Aug-02-2023 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000897069-23-001068 ( Act) Size: 12 KB |
Aug-02-2023 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000897069-23-001066 ( Act) Size: 11 KB |
Aug-02-2023 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000897069-23-001064 ( Act) Size: 12 KB |
Aug-02-2023 |
Recent 20 filings. View all Mira1a Therapeutics, Inc. filings
Thanks I look forward to using the product to improve my skin tone
young lad who new his job ansered questions and new what was best for me.
Very good communication and delivery made within the timeframe I was advised of
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by